Related Experiment Video
Updated: Jun 11, 2026
09:35
Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020
Stem cell models of cardiac development and disease
Kiran Musunuru1, Ibrahim J Domian, Kenneth R Chien
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Annual Review of Cell and Developmental Biology
|July 8, 2010
Summary
Patient-specific stem cell models now allow studying genetic cardiovascular diseases. These models aid in understanding disease mechanisms and screening for new drugs.
Area of Science:
- Stem cell biology
- Human genetics
- Cardiovascular disease research
Background:
- Recent advances in stem cell biology and human genetics enable patient-specific cell and tissue models.
- Identification of cardiovascular progenitor cells and genetic variants for heart disorders is crucial.
Purpose of the Study:
- To review the role of progenitor cells in cardiogenesis.
- To outline the application of pluripotent stem cells in modeling genetically-based cardiovascular disorders.
- To highlight the need for efficient model implementation for molecular understanding and therapeutic screening.
Main Methods:
- Review of current literature on stem cell biology and cardiovascular genetics.
- Application of pluripotent stem cells for disease modeling.
- In silico and in vitro screening strategies for therapeutic targets.
Main Results:
- Patient-specific cell and tissue models for cardiovascular diseases are now feasible.
- Pluripotent stem cells offer a platform for modeling genetic cardiovascular conditions.
- Challenges remain in efficiently implementing these models for drug and gene screening.
Conclusions:
- Stem cell-derived cardiovascular models hold significant promise for understanding genetic heart diseases.
- Efficient implementation is key to advancing molecular insights and developing novel therapeutics.
- This approach facilitates the discovery of genes and drugs influencing cardiovascular disease progression.
